medigraphic.com
ISSN 2007-3194 (Print)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México

2020, Number 1

<< Back Next >>

Arch Inv Mat Inf 2020; 11 (1)

Resolution of pregnancy complicated by maternal osteogenesis imperfecta. A case report

Villeda BD, Sánchez HJ, Carrillo MR

Language: Spanish
References: 13
Page: 27-31
PDF size: 152.27 Kb.


ABSTRACT

Osteogenesis imperfecta (OI) is a rare genetic disorder, commonly caused by an autosomal dominant mutation in genes that encode alpha-1 and alpha-2 chains of type I collagen, an important structural protein in the formation of bone, tendon, ligament, skin and sclerotic. A maternal OI has been estimated to occur only once every 25 000 to 30 000 pregnancies, because of this the obstetrician may have no experience in treat in pregnant women with the disease; these patients have high obstetric risk pregnancies and require a multidisciplinary team to follow up. We present a case of a patient with maternal imperfect osteogenesis who comes tour hospital for a pregnancy of 20 weeks of complicated gestation with early fetal death, where the main objective was to determine the behavior to be followed for the resolution of the pregnancy, which was terminated by vaginal delivery, without any complication or incident. Although there is still controversy about what is the best way to end pregnancy in these patients, the literature reports on the success of both cesarean deliveries and vaginal deliveries, concluding that the optimal mode of delivery must be decided individually.


REFERENCES

  1. van Dijk FS, Cobben JM, Kariminejad A, Maugeri A, Nikkels PGJ, van Rijn RR et al. Osteogenesis imperfecta: a review with clinical examples, Mol Syndromol, 2011; 2 (1): 1-20.

  2. Krishnamoorthy U, Vausse S, Donnai P. Management of pregnancy complicated by maternal osteogenesis imperfecta. Report of a case with uterine rupture, J Obstet Gynaecol, 2002; 22 (3): 316.

  3. Michell C, Patel V, Amirfeyz R, Gargan M. Osteogenesis imperfecta, Curr Orthop, 2007; 21: 236-241.

  4. Lyra TG, Fernandes PVA, Barbosa IFA, dos Santos NJ. Osteogenesis imperfecta in pregnancy. Case report, Rev Bras Anestesiol, 2010; 60 (3): 321-324.

  5. Cozzolino M, Perelli F, Maggio L, Coccia ME, Quaranta M, Gizzo S et al. Management of osteogenesis imperfecta type I in pregnancy; a review of literature applied to clinical practice, Arch Gynecol Obstet, 2016; 293 (6): 1153-1159.

  6. McAllion SJ, Paterson CR. Musculo-skeletal problems associated with pregnancy in women with osteogenesis imperfecta, J Obstet Gynaecol, 2002; 22 (2): 169-172.

  7. Borde M, Othaix D, Viroga S. Osteogénesis imperfecta y embarazo: reporte de un caso, Horizonte Médico (Lima), 2019; 19 (3): 84-88.

  8. Tsvieli O, Sergienko R, Sheiner E. Risk factors and perinatal outcome of pregnancies complicated with cephalopelvic disproportion: a population-based study, Arch Gynecol Obstet, 2012; 285 (4): 931-936.

  9. Cubert R, Cheng EY, Mack S, Pepin MG, Byers PH. Osteogenesis imperfecta: mode of delivery and neonatal outcome, Obstet Gynecol, 2001; 97: 66-69.

  10. Key TC, Horger EO 3rd. Osteogenesis imperfecta as a complication of pregnancy, Obstet Gynecol, 1978; 51: 67-71.

  11. Ruiter-Ligeti J, Czuzoj-Shulman N, Spence AR, Tulandi T, Abenhaim HA. Pregnancy outcomes in women with osteogenesis imperfecta: a retrospective cohort study, J Perinatol, 2016; 36 (10): 828-831.

  12. Hathaway WE, Solomons CC, Ott JE. Platelet function and pyrophosphates in osteogenesis imperfecta. Blood, 1972; 39: 500-509.

  13. Litos M, Michala S, Brown R. Osteogenesis imperfecta and pregnancy, Eur J Obstet Gynecol Reprod Biol, 2008; 136: 126-127.




2020     |     www.medigraphic.com